OpGen Revenue and Competitors
Estimated Revenue & Valuation
- OpGen's estimated annual revenue is currently $14.4M per year.
- OpGen received $12.0M in venture funding in February 2018.
- OpGen's estimated revenue per employee is $155,000
- OpGen's total funding is $158.7M.
Employee Data
- OpGen has 93 Employees.
- OpGen grew their employee count by -13% last year.
OpGen's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Financial Officer | Reveal Email/Phone |
3 | Full Line Sales Specialist | Reveal Email/Phone |
4 | IHC Systems Sales Specialist | Reveal Email/Phone |
5 | Corporate Controller | Reveal Email/Phone |
OpGen Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.3M | 2 | 0% | N/A | N/A |
#2 | $3.6M | 46 | -31% | $17.5M | N/A |
#3 | $3.6M | 46 | -34% | $10.5M | N/A |
#4 | $30.2M | 156 | 0% | $69.4M | N/A |
#5 | $11.8M | 76 | -15% | N/A | N/A |
#6 | $1.7M | 11 | 0% | N/A | N/A |
#7 | $2.5M | 16 | 0% | N/A | N/A |
#8 | $8.8M | 57 | 19% | N/A | N/A |
#9 | $0.2M | 1 | -86% | N/A | N/A |
#10 | $2M | 13 | 18% | N/A | N/A |
What Is OpGen?
OpGen, Inc. (NASDAQ: OPGN) is harnessing the power of informatics and genomic analysis to provide complete solutions for infection prevention and treatment. Using our large and ever-growing Acuitas Lighthouse® Knowledgebase of pathogens from around the world, we are developing disruptive technologies aimed to shift the paradigm for managing infectious diseases. Today, through our CLIA-certified clinical laboratory services, we provide rapid detection and analysis of antibiotic resistance and high resolution microbial sequence analysis. Our FDA-cleared, IVD products rapidly identify pathogens in positive blood cultures.
keywords:Analytics,Biotechnology,Healthcare,Medical Diagnostics,Pharmaceuticals
$158.7M
Total Funding
93
Number of Employees
$14.4M
Revenue (est)
-13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
OpGen News
OpGen logo StockNews.com began coverage on shares of OpGen (NASDAQ:OPGN Get Rating) in a research note issued to investors on Saturday.
(Nasdaq: OPGN, OpGen), a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious...
OpGen, Inc. (Rockville, MD, USA) is a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat...
ROCKVILLE, Md., Oct. 18, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or the “Company”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, today announced the closing of its previously announced registe ...
OpGen Announces $15 Million Registered Direct Offering ROCKVILLE, Md., Oct. 14, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, "OpGen" or the "Company"), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, today a ...
Other Companies in Gaithersburg
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $20M | 95 | 48% | N/A |
#2 | $7.5M | 97 | 1% | N/A |
#3 | $30.2M | 97 | -18% | N/A |
#4 | $14.1M | 97 | 1% | N/A |
#5 | $28.4M | 98 | 27% | N/A |
OpGen Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2002-12-20 | $2.3M | B | Mason Wells Biomedical | Article |
| 2005-01-25 | $5.0M | B | Article | |
| 2007-09-14 | $23.6M | A | CHL Medical Partners, Highland Capital Partners | Article |
| 2010-09-28 | $17.0M | B | jVen Capital | Article |
| 2012-03-08 | $17.0M | Undisclosed | Harris & Harris Group, Cross Creek Capital | Article |
| 2014-04-08 | $4.0M | Undisclosed | Article | |
| 2014-04-11 | $15.6M | Undisclosed | Multiple | Article |
| 2015-07-16 | $6.0M | Undisclosed | Merck GHI | Article |
| 2016-05-31 | $7.2M | Undisclosed | Article | |
| 2016-06-02 | $10.4M | Undisclosed | Merck Global Health Innovation Fund | Article |
| 2016-11-23 | $6.0M | Undisclosed | Merck Global Health Innovation Fund | Article |
| 2017-07-14 | $10.0M | Undisclosed | H.C. Wainwright & Co | Article |
| 2018-02-08 | $12.0M | Undisclosed | H.C. Wainwright & Co | Article |